MEDVi Quad benefits come from its combination of PDE5 inhibitors and a dopamine agonist. These ingredients are clinically studied to support blood flow, erection quality, arousal response, and overall sexual performance.
1. Supports Stronger Erections and Blood Flow
The primary benefit comes from PDE5 inhibitors (sildenafil, tadalafil, vardenafil), which improve nitric oxide signaling and increase blood flow to penile tissue.
Clinical trials show sildenafil significantly improved erectile function compared to placebo across multiple populations, including men with diabetes and cardiovascular risk factors.
A large review published in The Journal of Urology found PDE5 inhibitors consistently enhance erection quality and success rates during intercourse.
Scientific Reference:
Goldstein I et al., 1998 – Sildenafil study (NEJM)
https://pubmed.ncbi.nlm.nih.gov/9791100/
2. Enhances Sexual Performance and Stamina
Tadalafil, one of the key ingredients, is known for its longer duration of action (up to 36 hours), allowing improved spontaneity and sustained performance.
A meta-analysis comparing tadalafil and sildenafil found tadalafil provided extended effectiveness and improved patient satisfaction due to longer activity windows.
This supports the claim that multi-ingredient formulas may help with both immediate response and prolonged performance.
Scientific Reference:
Gong B et al., 2017 – Meta-analysis
https://pmc.ncbi.nlm.nih.gov/articles/PMC5603624/
3. May Improve Libido and Arousal Response
Apomorphine works differently from PDE5 inhibitors. It targets the central nervous system, activating dopamine receptors involved in sexual desire and arousal.
Studies show sublingual apomorphine can improve erectile response by stimulating brain pathways responsible for sexual function.
This makes it particularly relevant for men with psychological or mixed ED causes.
Scientific Reference:
Mulhall JP et al., 2001
https://pubmed.ncbi.nlm.nih.gov/11829718/
4. Faster Onset of Action
Sublingual delivery and fast-acting PDE5 inhibitors like sildenafil and vardenafil are associated with quicker onset times compared to traditional oral tablets.
Research indicates sildenafil can begin working within 30 minutes, with some faster onset depending on formulation and absorption.
This aligns with the idea of rapid absorption seen in sublingual ED treatments.
Scientific Reference:
FDA Label – Sildenafil
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/20895s039s042lbl.pdf
5. Improves Overall Sexual Confidence
Improved erection quality and performance can lead to better psychological outcomes, including increased confidence and reduced performance anxiety.
Clinical research highlights that successful ED treatment is associated with improved quality of life, relationship satisfaction, and mental well-being.
This is an indirect but important benefit supported by ED treatment studies.
Scientific Reference:
Althof SE, 2002 – Psychological outcomes in ED
https://pubmed.ncbi.nlm.nih.gov/12088100/
6. May Help in Difficult-to-Treat Cases
Combination therapy is often explored when single medications do not provide sufficient results.
A review in Translational Andrology and Urology suggests that multi-drug approaches may benefit men who do not respond fully to single-agent PDE5 inhibitors.
This supports the idea behind multi-ingredient ED formulations like MEDVi Quad.
Scientific Reference:
Dhir RR et al., 2011
https://pmc.ncbi.nlm.nih.gov/articles/PMC3739353/